Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
PUT
Blackrock
BLK
$182B
| $335K | 0.01% |
+500
| New | +$352K |
|
1852
LeMaitre Vascular
LMAT
$1.83B
| $335K | 0.01% |
6,513
+1,414
| +28% | +$68.6K |
|
1853
Mitek Systems
MITK
$806M
| $335K | 0.01% |
+34,927
| New | +$335K |
|
|
SCHW
1854
PUT
Charles Schwab
SCHW
$197B
| $335K | 0.01% |
6,400
-5,100
| -44% | -$373K |
|
1855
Seer Inc
SEER
$113M
| $334K | 0.01% |
86,655
+63,530
| +275% | +$292K |
|
1856
CALL
Zillow
Z
$8.33B
| $334K | 0.01% |
+7,500
| New | +$319K |
|
1857
Arcutis Biotherapeutics
ARQT
$3.11B
| $333K | 0.01% |
+30,306
| New | +$438K |
|
1858
CALL
Allstate
ALL
$65.8B
| $331K | 0.01% |
+3,000
| New | +$379K |
|
1859
AnaptysBio
ANAB
$1.73B
| $330K | 0.01% |
+15,184
| New | +$369K |
|
1860
PUT
Centene
CNC
$32.4B
| $329K | 0.01% |
+5,200
| New | +$369K |
|
1861
iShares MSCI EAFE Value ETF
EFV
$31.8B
| $329K | 0.01% |
+6,788
| New | +$329K |
|
1862
PUT
Nabors Industries
NBR
$1.31B
| $329K | 0.01% |
2,700
-100
| -4% | -$15.1K |
|
|
CSII
1863
DELISTED
Cardiovascular Systems, Inc.
CSII
| $329K | 0.01% |
16,589
-50,287
| -75% | -$868K |
|
1864
PUT
Danaher
DHR
$151B
| $328K | 0.01% |
+1,466
| New | +$333K |
|
1865
CALL
Meritage Homes
MTH
$4.73B
| $327K | 0.01% |
+5,600
| New | +$301K |
|
1866
Genesco
GCO
$390M
| $326K | 0.01% |
8,830
-23,054
| -72% | -$1.01M |
|
1867
CALL
Helmerich & Payne
HP
$4.25B
| $326K | 0.01% |
+9,100
| New | +$393K |
|
1868
Alcon
ALC
$35.6B
| $325K | 0.01% |
+4,611
| New | +$328K |
|
1869
Dick's Sporting Goods
DKS
$16.1B
| $325K | 0.01% |
2,294
-8,234
| -78% | -$1.1M |
|
1870
PUT
Omega Healthcare
OHI
$14.1B
| $325K | 0.01% |
+11,900
| New | +$331K |
|
1871
Arch Capital
ACGL
$34.5B
| $324K | 0.01% |
+4,774
| New | +$314K |
|
|
MRUS
1872
DELISTED
Merus
MRUS
| $324K | 0.01% |
17,615
-5,600
| -24% | -$97.6K |
|
1873
PUT
Wayfair
W
$14.1B
| $324K | 0.01% |
9,400
-1,300
| -12% | -$57.6K |
|
1874
CALL
Fluor
FLR
$6.86B
| $323K | 0.01% |
+10,400
| New | +$358K |
|
1875
CALL
Northrop Grumman
NOC
$78B
| $323K | 0.01% |
700
-1,500
| -68% | -$696K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.